Quince Therapeutics, Inc. (QNCX) Operating income 2018–2025
Quince Therapeutics, Inc. (QNCX) annual operating income history from SEC filings — each fiscal year as reported.
-$58.1MFY2025 · since FY2018: -$12.1M → -$58.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$58.1M | -1.4% |
| FY2024 | -$57.3M | -65.5% |
| FY2023 | -$34.6M | +33.4% |
| FY2022 | -$52.0M | +42.4% |
| FY2021 | -$90.3M | -14.5% |
| FY2020 | -$78.9M | -101.4% |
| FY2019 | -$39.2M | -223.2% |
| FY2018 | -$12.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice